Two-medication strategy offers both benefit and risk after coronary artery bypass surgery
A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery—while also increasing the risk of potentially dangerous bleeding. This double-edged ...
Aug 9, 2022
0
70
